Classification of Korean botulinum - beauty secrets

Views: 7     Author: Site Editor     Publish Time: 2022-11-25      Origin: Site

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
kakao sharing button
snapchat sharing button
sharethis sharing button

botox dermax online supply

Dermax is a leading botulinum toxin type A, such as Nabota, Meditoxin, Rentox, Botulax (botox) online supplier from China. Dermax has been supplying high-quality botulinum toxin to customers worldwide and at home for about 7 years. In addition to Nabota, Dermax has developed a collection of botulinum toxin type A including Botulax 100u and 200u, Nabota 100u and 200u, Meditoxin 100u, 150u and 200u, Hutox, and Re N Tox 100u and 200u.

Korean botulinum Botulax, also known as 白毒. Korean second-generation biotechnology Botulax, compared with the first Botulax has been significantly improved, BPTULAX is mainly used to improve wrinkles between the eyebrows, forehead, around the eyes, corners of the mouth, etc., treatment of functional wrinkles caused by facial muscle contraction. It also has excellent results in improving muscular square faces.  

Features: relatively mild and stable, slightly slower effect, about half a month to see the effect; The maintenance time is longer than that of powder poison, which is more suitable for wrinkle removal; After 3 months, the injection was supplemented, and the injection was given 3 times in a row.  

Powder Botulinum Toxin

Produced by Korea Pacific Pharmaceutical Company, ranking fourth in the world.  

This product, which is produced entirely on Korean technology, has the same effect as BOTOX and is used to remove wrinkles and improve skin wrinkles, and is mainly packaged in 100 units, and recently there are also 20 units on the market.  

It has the largest market share in Korea and also exports abroad. Mainly suitable for facial wrinkles, square face and face lift.  

Features: The most common in Korean hospitals, with rapid results, but short maintenance time.  

South Korea's Daebear Pharmaceutical Company products are more pure, not easy to produce antibodies, long maintenance time, more suitable for people who have been beaten with botulinum poison many times, and other aspects are not much different from powdered meat, and its packaging is mainly 100U (unit).  

Features: Not easy to produce antibodies, long maintenance time.  

韩国 botox

Nabota 绿毒 comes in 100u (unit) & 200u (unit) two packages, 100u for face slimming, 200u for slimming calf muscles, 3 months apart for injections, 3 times of styling.  

Many people will confuse the relationship between Korean green poison and powder poison and white poison, but in fact, powder poison and white poison are produced by South Korea Pacific Pharmaceutical, and green poison is a product of Daebear Pharmaceutical, which has not yet obtained CFDA certification, so it is necessary to remind beauty seekers to use it with caution.  

At the same time, according to the data, South Korea's Daxiong Pharmaceutical established Beijing Daxiong Weiye Pharmaceutical Technology Co., Ltd. in China, mainly to conduct clinical phase III trials of safety and efficacy in the Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China.  

The products produced by South Korea's Daebear Pharmaceutical Company are higher purity than powder poison, and some data say that it is not easy to produce antibodies, and the maintenance time is longer, which is more suitable for people who have been beaten with botulinum many times.  

Orange botulinum toxin, Hutox is also a brand botulinum toxin derived from South Korea, but it belongs to the Korean powerful pharmaceutical company HUONS. This pharmaceutical company has also created Elravie hyaluronic acid, which has been certified by China's CFDA, and the quality of its products has been praised by major doctors and beauty seekers.  

The specification is 100U, and 0°~4° is required for refrigerated storage. It is worth mentioning that Orange Poison signed an agreement with Aimeke to authorize it to become a partner, and Huons hopes to launch clinical trials and product licensing in China through Aimeke.  

The prospectus released by Aimeke at the time of listing shows that orange poison is currently in the clinical trial stage, and some brokerages expect that Hutox will be listed in China in 2024.